Systemic sclerosis and calcinosis cutis: Response to rituximab

Journal of Clinical Pharmacy and Therapeutics

Volumn 41, Issue 1, 2016, Pages 94-96

  Poormoghim, H ^a   Andalib, E ^a   Almasi, A R ^a   Hadibigi, E ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

calcinosis; rituximab; systemic sclerosis

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CALCIUM; COLCHICINE; DILTIAZEM; MAGNESIUM; OMEPRAZOLE; PARATHYROID HORMONE; PHOSPHORUS; PREDNISONE; RITUXIMAB; WARFARIN;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CASE REPORT; CAUCASIAN; FEMALE; FINGER ULCER; FOOT ULCER; GASTROESOPHAGEAL REFLUX; HEMATOCRIT; HIP INJURY; HIP PAIN; HIP RADIOGRAPHY; HUMAN; INGUINAL REGION; LOW DRUG DOSE; MIDDLE AGED; PHYSICAL EXAMINATION; RAYNAUD PHENOMENON; SHOULDER DISEASE; SKIN CALCIFICATION; SKIN DEFECT; SOFT TISSUE CALCIFICATION; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE; CALCINOSIS; DISEASE COURSE; PATHOLOGY; SCLERODERMA, SYSTEMIC; SKIN DISEASES; TREATMENT FAILURE; TREATMENT OUTCOME;

CALCINOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; RITUXIMAB; SCLERODERMA, SYSTEMIC; SKIN DISEASES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84957109314     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12340     Document Type: Article

References (10)

1. Boulman N, Slobodin G, Rozenbaum M, Rosner I,. Calcinosis in rheumatic diseases. Semin Arthritis Rheum, 2005; 34: 805-812.
2. Yoshida S, Torikai K., The effects of warfarin on calcinosis in a patient with systemic sclerosis. J Rheumatol, 1993; 20: 1233-1235.
3. Asano Y, Ihn H, Asashima N, et al,. A case of diffuse scleroderma successfully treated with highdose intravenous immune globulin infusion. Rheumatology, 2005; 44: 824-826.
4. Fujii N, Hamano T, Isaka Y, Ito T, Imai E,. Risedronate: a possible treatment for extraosseous calcification. Clin Calcium, 2005; 1S: 75-78.
5. Al-Mayouf SM, Alsonbul A, Alismail K., Localized calcinosis in juvenile dermatomyositis: successful treatment with intralesional corticosteroids injection. Int J Rheum Dis, 2010; 13: e26-e28.
6. Fuchs D, Fruchter L, Fishel B, Holtzman M, Yaron M,. Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol, 1986; 5: 527-530.
7. Daoussis D, Antonopoulos I, Liossis SN, Yiannopoulos G, Andonopoulos AP,. A case report of Rituximab-induced regression of CREST-related Calcinosis and review of the literature. Semin Arthritis Rheum, 2012; 41: 822-829.
8. de Paula DR, Klem FB, Lorencetti PG, Muller C, Azevedo VF,. Rituximab-induced regression of CREST-related calcinosis. Clin Rheumatol, 2013; 32: 281-283.
9. Hurabielle C, Allanore Y, Kahan A, Avouac J., Flare of calcinosis despite rituximab therapy. Semin Arthritis Rheum, 2014; 44: e5-e6.
10. LeRoy EC, Black C, Fleischmajer R, et al,. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol, 1988; 15: 202-205.